AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2017
Nov 9, 2017
35274_dirs_2017-11-09_31a3c134-579e-495f-a81f-18519e2a06fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2017-11-07
Reporting Person: Daly Richard J (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-07 | Common Stock Purchase Option | $1.12 | A | 100000 | Acquired | 2027-11-07 | Common Stock (100000) | Direct |
Footnotes
F1: Represents a discretionary grant to Employee. The options vest quarterly on 2/718, 5/7/18, 8/7/18, and 11/7/18.
More from PALISADE BIO, INC.
Regulatory Filings
2026
Jun 11
Share Issue/Capital Change
2026
Jun 10
Capital/Financing Update
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Capital/Financing Update
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13